Pain relief after skin cancer surgery: new drug vs standard
Treatments studied
Part of Cancer, Skin clinical trials.
This study compares a new pain medication (suzetrigine) to a common pain reliever (Norco) for people recovering from Mohs micrographic surgery, a specialized procedure to remove skin cancer. The goal is to see if the new medication works better and is safer for post-surgery pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 89 years old
- You had a skin tumor (cutaneous tumor) removed using Mohs micrographic surgery (MMS)
- You do not have liver disease or liver problems
- You are not currently taking medications that interact with a liver enzyme called CYP3A
- You are willing to take either the new medication (suzetrigine) or the standard medication (Norco) for pain relief
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests local anesthetics (numbing medicines) used during Mohs micrographic surgery, a specialized procedure for skin cancer. Researchers want to understand how well these numbing agents work and improve patient comfort during the procedure.
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
This trial tests if a new non-opioid drug, suzetrigine, works as well as Norco for pain after wisdom tooth extraction or jaw surgery. If effective, it could provide a safer alternative without opioid risks.
This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.
This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.
This study tests if meloxicam, an anti-inflammatory painkiller, helps control pain after Mohs surgery for skin cancer. It aims to reduce the need for stronger opioid pain medicines.
Hear when a new Mohs Micrographic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.